SCHEMBL15214993

SCHEMBL15214993

C#Cc1ccc(S(=O)(=O)N2CCC(c3ccc(CC)cc3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
LMNA P02545 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
TP53 P04637 3/20 0.52
HTT P42858 2/20 0.49
APOBEC3A P31941 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
USP5 P45974 7/20 0.45
MEN1 O00255 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
HDAC6 Q9UBN7 1/20 0.44
THRB P10828 1/20 0.44
HSD11B1 P28845 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215001 0.90 ALDH1A1 (0.66) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL10243199 0.88 ALDH1A1 (0.55) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL10245136 0.84 ALDH1A1 (0.59) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL31055719 0.77 NPY5R (0.41) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL4518520 0.76 MEN1 (0.57) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL15214992 0.76 FASN (0.50) SMN1; SMN2MEN1KMT2AHSD11B1
SCHEMBL12189232 0.74 ALDH1A1 (0.72) ALDH1A1LMNAL3MBTL1TP53HTT
SCHEMBL12188938 0.73 ALDH1A1 (0.70) ALDH1A1LMNAL3MBTL1HTTSMN1; SMN2
SCHEMBL8646353 0.72 USP2 (0.68) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL12646347 0.72 USP2 (0.68) ALDH1A1LMNAL3MBTL1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150038708-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-05 US disclosed
US-8846707-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein UNIVERISTY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-09-30 US disclosed
US-20130225621-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN UNIVERSITY OF TORONTO MISSISSAUGA (CA) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038708-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN STAT3, STAT1, STAT4 ALDH1A1 4285/4885LMNA 4192/4885L3MBTL1 2601/4885
US-20130225621-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN STAT3, STAT1, STAT4 ALDH1A1 4285/4885LMNA 4192/4885L3MBTL1 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.